Evolent Health, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Evolent Health, Inc. (EVH) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2026-02-25
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-12-31 was $0.00.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2025-03-31 was $0.00.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2024-09-30 was $9.00M.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2024 was $9.00M, a 87.18% decline from fiscal 2023.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2023 was $70.20M, a 6.40% decline from fiscal 2022.
- Evolent Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2022 was $75.00M, a 413.70% increase from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $9.00M derived: sum of 3 quarters · filed 2026-02-25 | $9.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.00M derived: sum of 2 quarters · filed 2026-02-25 | $9.00M derived: sum of 3 quarters · filed 2026-02-25 | $9.00M 10-K · filed 2026-02-25 |
| 2024-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $9.00M derived: sum of 2 quarters · filed 2025-11-07 | $9.00M 10-Q · filed 2025-11-07 | $12.60M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | $3.60M derived: sum of 3 quarters · filed 2025-05-09 | $3.60M derived: sum of 4 quarters · filed 2025-05-09 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-09 | $3.60M derived: sum of 2 quarters · filed 2025-05-09 | $3.60M derived: sum of 3 quarters · filed 2025-05-09 | $439.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $3.60M derived: sum of 2 quarters · filed 2025-02-21 | $439.00K derived: sum of 3 quarters · filed 2025-02-21 | $70.20M 10-K · filed 2025-02-21 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$3.16M derived: sum of 2 quarters · filed 2024-11-08 | $66.60M 10-Q · filed 2024-11-08 | $66.60M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$3.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $66.60M 10-Q · filed 2024-08-09 | $66.60M derived: sum of 3 quarters · filed 2024-08-09 | $141.60M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $69.76M 10-Q · filed 2024-05-10 | $69.76M derived: sum of 2 quarters · filed 2024-05-10 | $144.76M derived: sum of 3 quarters · filed 2024-05-10 | $144.76M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $75.00M derived: sum of 2 quarters · filed 2024-02-23 | $75.00M derived: sum of 3 quarters · filed 2024-02-23 | $75.00M 10-K · filed 2024-02-23 |
| 2022-09-30 | $75.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $75.00M derived: sum of 2 quarters · filed 2023-11-02 | $75.00M 10-Q · filed 2023-11-02 | $89.60M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $14.60M derived: sum of 3 quarters · filed 2023-08-03 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $14.60M derived: sum of 2 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $14.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $14.60M 10-K · filed 2023-02-24 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |